189 related articles for article (PubMed ID: 33020149)
41. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis.
Bashari D; Hacohen D; Ginsberg D
Cell Signal; 2011 Jan; 23(1):65-70. PubMed ID: 20800677
[TBL] [Abstract][Full Text] [Related]
42. Regulatory effects of programmed cell death 4 (PDCD4) protein in interferon (IFN)-stimulated gene expression and generation of type I IFN responses.
Kroczynska B; Sharma B; Eklund EA; Fish EN; Platanias LC
Mol Cell Biol; 2012 Jul; 32(14):2809-22. PubMed ID: 22586265
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure of the eIF4A-PDCD4 complex.
Chang JH; Cho YH; Sohn SY; Choi JM; Kim A; Kim YC; Jang SK; Cho Y
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3148-53. PubMed ID: 19204291
[TBL] [Abstract][Full Text] [Related]
44. A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma.
Liu P; Zhang X; Li Z; Wei L; Peng Q; Liu C; Wu Y; Yan Q; Ma J
Biochem Biophys Res Commun; 2020 Apr; 524(4):816-824. PubMed ID: 32044038
[TBL] [Abstract][Full Text] [Related]
45. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
[TBL] [Abstract][Full Text] [Related]
46. E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.
Hughes TA; Brady HJ
Biochem Biophys Res Commun; 2005 Apr; 329(4):1267-74. PubMed ID: 15766563
[TBL] [Abstract][Full Text] [Related]
47. Distinctions in the specificity of E2F function revealed by gene expression signatures.
Black EP; Hallstrom T; Dressman HK; West M; Nevins JR
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15948-53. PubMed ID: 16249342
[TBL] [Abstract][Full Text] [Related]
48. eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.
González-Ortiz A; Pulido-Capiz A; Castañeda-Sánchez CY; Ibarra-López E; Galindo-Hernández O; Calderón-Fernández MA; López-Cossio LY; Díaz-Molina R; Chimal-Vega B; Serafín-Higuera N; Córdova-Guerrero I; García-González V
Cells; 2022 Dec; 11(24):. PubMed ID: 36552834
[TBL] [Abstract][Full Text] [Related]
49. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.
Cloud JE; Rogers C; Reza TL; Ziebold U; Stone JR; Picard MH; Caron AM; Bronson RT; Lees JA
Mol Cell Biol; 2002 Apr; 22(8):2663-72. PubMed ID: 11909960
[TBL] [Abstract][Full Text] [Related]
50. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
Iwasaki S; Floor SN; Ingolia NT
Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
[TBL] [Abstract][Full Text] [Related]
51. E2F1 is crucial for E2F-dependent apoptosis.
Lazzerini Denchi E; Helin K
EMBO Rep; 2005 Jul; 6(7):661-8. PubMed ID: 15976820
[TBL] [Abstract][Full Text] [Related]
52. P44/WDR77 restricts the sensitivity of proliferating cells to TGFβ signaling.
Yi P; Gao S; Gu Z; Huang T; Wang Z
Biochem Biophys Res Commun; 2014 Jul; 450(1):409-15. PubMed ID: 24944016
[TBL] [Abstract][Full Text] [Related]
53. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
Waldron JA; Tack DC; Ritchey LE; Gillen SL; Wilczynska A; Turro E; Bevilacqua PC; Assmann SM; Bushell M; Le Quesne J
Genome Biol; 2019 Dec; 20(1):300. PubMed ID: 31888698
[TBL] [Abstract][Full Text] [Related]
54. Specificity in the activation and control of transcription factor E2F-dependent apoptosis.
Hallstrom TC; Nevins JR
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10848-53. PubMed ID: 12954980
[TBL] [Abstract][Full Text] [Related]
55. Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2.
Liwak U; Thakor N; Jordan LE; Roy R; Lewis SM; Pardo OE; Seckl M; Holcik M
Mol Cell Biol; 2012 May; 32(10):1818-29. PubMed ID: 22431522
[TBL] [Abstract][Full Text] [Related]
56. eIF4G2 balances its own mRNA translation via a PCBP2-based feedback loop.
Smirnova VV; Shestakova ED; Bikmetov DV; Chugunova AA; Osterman IA; Serebryakova MV; Sergeeva OV; Zatsepin TS; Shatsky IN; Terenin IM
RNA; 2019 Jul; 25(7):757-767. PubMed ID: 31010886
[TBL] [Abstract][Full Text] [Related]
57. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
[TBL] [Abstract][Full Text] [Related]
58. Staufen1 is Essential for Cell-Cycle Transitions and Cell Proliferation Via the Control of E2F1 Expression.
Ghram M; Bonnet-Magnaval F; Hotea DI; Doran B; Ly S; DesGroseillers L
J Mol Biol; 2020 Jun; 432(13):3881-3897. PubMed ID: 32335035
[TBL] [Abstract][Full Text] [Related]
59. eIF4A1-dependent mRNAs employ purine-rich 5'UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation.
Schmidt T; Dabrowska A; Waldron JA; Hodge K; Koulouras G; Gabrielsen M; Munro J; Tack DC; Harris G; McGhee E; Scott D; Carlin LM; Huang D; Le Quesne J; Zanivan S; Wilczynska A; Bushell M
Nucleic Acids Res; 2023 Feb; 51(4):1859-1879. PubMed ID: 36727461
[TBL] [Abstract][Full Text] [Related]
60. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
Cuesta R; Holz MK
Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
